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ABSTRACT
This study is designed to investigate the main risk factors, which increased the incidence of
schizophrenia and the rate of fertility in patients measuring sex hormones (testosterone and
estrogen) and prolactin hormone. The aim of study was to evaluate the fertility rate and risk
factors of schizophrenia. Blood samples were collected for measuring the hormones from 108
individual divided groups: Patients’ group that contain 78 patients and a control group, which
included 30 healthy persons. The results showed that schizophrenia was higher in male than
female. Tobacco smoking and family history have significantly risk for most patients which
lived in urban areas. There was statistical significance (P ≤ 0.05) in the testosterone hormones
between patients group and control group. It is concluded that patients were suffering from
hypogonadism, in contrasts with the prolactin hormone, which has been indicated significant
increasing of schizophrenia.
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1. INTRODUCTION
450 Million People have been undergoing from mental and behavioral disorders worldwide.
One person in four is developing of these diseases during lifetime [1]. Schizophrenia is a
drastic mental illness featured by cognitive deficits as well as vocational impairment and
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interpersonal hurdles. Individuals, who have schizophrenia also suffer from deficits in
everyday and limits in alertness, focus and vigilance [2]. The illness has been affecting nearly
1% of world’s population and accounts of 1-2% of national health care outlays in industrial
countries [2,3]. The disease excessively impairs many of cognitive domains, including
memory, attention and executive function, and usually causes a lifetime of disability and strict
emotional distress for smitten persons [4]. Many disorder cases were first diagnosed at the age
of 20 - 25 years. At this span of life people typically obtain emancipation from parents,
engaging in significant romantic relationships, beginning to look for a job or career [5].
Improvement in schizophrenia has painfully tardy and limited via a number of factors, such as
the heterogeneity of the schizophrenia phenotype and the absence of clear pathological lesions
like the study of Alzheimer’s disease, Parkinson’s disease, and neurodegenerative disorders
[6].
The best description of schizophrenia is a heterogeneous syndrome without any symptom or
sign and it is unidentifiable with any recognized diagnostic laboratory tests [7]. This disorder
has many factors may explain the etiology of it, with different susceptibility genes that have
been interacted with environmental causes to produce a range of phenotypes in the series of
schizophrenia [8]. Schizophrenia first steps during the reproductive period contain a relation
between this disorder and the sudden brain changes and the body occurring in adolescence
stage and throughout the fertility stage. In adolescence, these deviations take inactivation and
amplification of the pulsed release of the gonadotropin-releasing hormone, an increase of 30-
folds of the release of LH in boys while an increase of 100-folds occurs in girls. As for the
gonads, a swift circulating estrogens and androgens are increased [9]. The aim of study is
evaluating the fertility rate and risk factors of schizophrenia.
2. MATERIALS AND METHODS
The number of schizophrenia patients was 78 diagnosed by psychiatrists in the mental
department, who were specialized in psychiatric disease in Alhakeem hospital that agrees with
(DSM-IV) standards of the American psychiatric association (APA). Another 30 healthy have
no suffering from any psychiatric or cardiovascular diseases and do not smoke, their ages
ranging between 20 to 70 years as in the patient group. The study was carried out during July
and September of 2014. The medical history of each patient was taken from their relatives,
which include age, sex, family history, type of diet and smoking habit. Body index is detected
by recording the weight of each patient and height. Blood samples were collected from the
patients and healthy individuals to obtain serum for measuring hormones (testosterone,
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prolactin, and estrogen). The measurement of hormones was done by using an enzyme-linked
immunosorbent assay by ELISA instrument using commercial kits for each hormone
(Monobind-USA).
Statistical Analysis
The statistical analysis of this study was done by using SPSS program (V. 17) and the
statistical processes used here were means, standard deviations, one-way ANOVA, and Chi-
square.
3. RESULTS
Figure 1 explains that schizophrenia was highly detected (41-50 years) (25 cases) followed by
24 cases (31-40 y), 16 cases (20-30 y), and nine cases (51-60 y). Whereas, only 4 cases were
noted at interval (61-70 y).
Fig.1. Distribution of age in schizophrenia patients
Fig.2. showed increased in the schizophrenia in a male with 59 cases. While, the incidence of
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Fig.2. Distribution of schizophrenia according to sex
Table 1 clarifies significant increase in the number of patients (smoking; 79.5%) as compared
to control group (no smoking).
Table 1. Distribution smoking among control and patient groups
Smoking Control group Patients’ group χ2 P value
No. % No. %
Yes 0 0 62 79.5%
55.46a 0.000No 30 100 16 20.5%
Total 30 100 78 100
a= significant differences when comparing with control groups at P<0.05 (statistical test is chi
square)
The majority of patients live in the urban area as shown in Table 2. Whereas, the rest of
subjects live in a rural area (23.3%) belongs to control group while, the percentage ratio
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Table 2 Distribution of control and patient groups according to the position of their living
area
Residence Control group Patients’ group χ2 P value
No. % No. %
Urban 23 76.7% 59 75.6%
0.012 0.91Rural 7 23.3% 19 24.4%
Total 30 100 78 100
The statistical test is chi square
The schizophrenia was characterized by increasing the value of Body Mass Index (BMI)
(27.32±6.74) as compared with control group (22.91±3.17) with a highly significant
difference (P<0.001) as shown in Table 3.
Table 3. BMI (kg m-2) in control and patient groups
Studied groups No. Mean±SD P value
Control group 30 22.91±3.17
0.001Patients’ group 78 27.32±6.74
Total 108 26.01±6.23
The statistical test is ANOVA one way
Table 4 shows that the testosterone hormone significantly P<0.05 decreased in patients group
(1.46±2.49) as compared with control group (5.18±3.07).
Table 4. Serum testosterone hormone level ng ml-1 in control and patient groups
Studied groups No. Mean±SD P value
Control group 30 5.18±3.07
0.000Patients’ group 78 1.46±2.49
Total 108 2.49±3.13
The statistical test is ANOVA one way
The number of schizophrenic, women in the patients group was 19; ten of them recorded
decreases in the levels of estrogen hormone. While, nine had a normal value of this hormone
as shown in Table 5.
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Table 5. Evaluation of estrogen hormone of women
Women decreased estrogen levels Women normal estrogen levels Total
No. % No. % No. %
10 53 9 47 19 100
A statistical test is frequencies
Table 6 shows a significant difference P≤0.033 in the level of prolactin hormone among the
studied groups. The hormone was elevated in patients (15.96±19.05) in comparison with
controls (8.41±2.07).
Table 6. Serum prolactin hormone levels (ng ml-1) in control and patient groups
4. DISCUSSION
In the present study incidence of schizophrenia was increased at interval age of (41-50 y) and
this result is approximately similar to what was reported by [10] who explained that
schizophrenia defined as the symptoms beyond age 44 years and accounts for nearly 15-20%
of all cases of schizophrenia. Schizophrenia is more common in male than female as in Figure
2, this result is quite similar to the findings of [11] who supposed that schizophrenia occurred
about twice as higher for male than female regardless of the specific diagnostic criteria which
is used for this purpose. The positive association of smoking with schizophrenia, which was
recorded in Table 1 is supported by [12] who elucidated that the rate of smoking among
schizophrenia patients could be increased when to compare with control. This is because
tobacco contains nicotine, which is featured as highly addictive chemical and quickly
absorbed by bloodstream. Nicotine in turn incentives dopamine production, a chemical
associated with a pleasurable sensation [13]. Smokers fast develop regular smoking patterns,
which guarantee release a stream of dopamine steadily. When the nicotine concentration in
their blood drops less than a certain level, smokers have been beginning to crave a cigarette.
Studied groups No. Mean±SD P value
Control group 30 8.41±2.07
0.033Patients’ group 78 15.96±19.05
Total 108 13.86±16.54
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This craving gives a feeling of ‘stress’ till the craving is relieved [14]. This research assessed
the association between obesity and schizophrenia by recording a significant increase in BMI
for patients in comparison with healthy persons, this result is confirmed with [15] who
reported that overweight has been affected patients taking antipsychotic treatment such as
schizophrenia. Weight gain is a trendy collateral effect of several drugs, including
antipsychotic agents. Patients dealing antipsychotics usually make use of drugs to remedy
psychiatric symptoms and/or clinical events common in the gross population. When patients
have been receiving multiple agents that bring about weight gain, the effects could be
addictive and lead to obesity [16]. The results of testosterone hormone in this study showed
significant decrease in hormone compared with control group. These results are supported by
Taherianfard and Shariaty who found decreasing of this hormone in serum of male compared
with healthy person [17]. The current findings provided a firm support for the concept
abnormal levels of steroids in serum of schizophrenia and could be involved in the
pathophysiological causes of schizophrenia, at least in male [18]. This study also found
significant increase of prolactin hormone of patients versus control which is similar to Garcia-
Rizo e al. 2012. It was noticed that antipsychotic-naïve patients newly diagnosed of
schizophrenia have higher hormone than control [19]. Hyperprolactinemia does not happen
because of the association of stress with the initiate of psychosis, but because of a pre-existing
vulnerability. Pre-existing vulnerability of schizophrenia depicted previously in other
metabolic areas that as well contribute to the secondary side effects of the antipsychotic drugs
[20]. Prolactin-releasing peptide (PrRP), a factor that is released from the hypothalamus in
mammals, could account for some of these findings, as its turmoil lead to metabolic disorders
[21] identical to first-episode psychosis.
5. CONCLUSION
There was statistical significance (P ≤ 0.05) in the testosterone hormones between patients
and control group. This means that patients were suffering from hypogonadism, in contrasts
with the prolactin hormone, which has been indicated significant increasing of schizophrenia.
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